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without cirrhosis revealed signiﬁcant risk factors for HCC as
follows: age (over 40 yrs old, p = 0.009), male (p = 0.011),
AFP (>20 ng/mL, p = 0.011), severe liver parenchymal echo-
pattern in ultrasonography (p = 0.0002) and heavy alcoholics
(p = 0.0428). Based on these factors, the establishment of
screening program for HCC is in the pipeline.
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I-67 Fungal infections Insights from the bench-side
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Invasive fungal infections have always been a life-
threatening disease for immunocompromised patients.
Traditionally, the microbiology laboratory often offers
little help in the diagnosis and treatment of these
patients. However, with the advent of molecular and
chemical diagnostic methods, and the standardization of
susceptibility testing, more insights can now be sheded.
Molecular techniques generally detect the presence of
the highly conserved region of the fungal organisms. Its
success has been variable, and standardization of methods
has been slow in progress. Chemical detection methods
such as mannan, galactomannan has received renewed
interest. The application of beta-D-glucan detection in the
clinical settings has raised further enthusiasm not only in
its high sensitivity, but also potentially as a monitoring
marker for disease progress and treatment response. Disc
diffusion susceptibility testing has allowed certain azole
agents to be readily tested in the laboratory. Although the
susceptibility of most Candida species can be predicted from
its speciation, the availability of susceptibility surveillance
programme allows monitoring of resistance pattern. The
advent of echinocandins further improves the clinical
outcomes. Its selective toxicity is a much needed contribute
in the treatment of these fatal diseases. With further
clinical trials and animal models, understanding of this class
of anti-fungal agent should widen its clinical application.
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Invasive fungal infection has emerged as an important
nosocomial infection, especially in critically ill patients.
An increasing incidence of candidemia became apparent
from the 1980 to the end of the 1990’s followed by relative
stability. The incidence of candidemia in intensive care
units (ICUs) is 5 to 10-fold that in overall hospitals, and
more than 100-fold greater than in the general population
in Asia-Paciﬁc region. The crude mortality rate of patients
with candidemia is in the range of 35 60%, however,
ICU patients with candidemia had a higher mortality rate
than non-ICU patients. The crude mortality with invasive
aspergillosis is more than 60%, particularly in patients
with hematological malignancy and transplant patients.
Candida albicans remains the predominant cause of invasive
candidiasis in more than 50% of all cases. C. tropicalis,
C. glabrata and C. parapsilosis are the three most common
non-albicans Candida species causing invasive candidiasis.
The above four Candida species account for more than
90% of invasive candidiasis. Overall, invasive non-albicans
Candida isolates remained highly susceptible to ﬂuconazole
(>90% susceptible) over the past two decades. However, the
susceptible rate of C. glabrata to ﬂuconazole varied widely
from 22 to 72% and the resistant rate ranged from 2 to 16% in
Asian countries. Analysis of the ﬂuconazole susceptibilities
of 204 bloodstream C. glabrata isolates revealed a rapid
shift from susceptible (64% in 1999 to 2001 to 19% in 2007)
to susceptible-dose dependent (27% in 1999 to 2001 and
75% in 2007) in Taiwan. Periodic surveillance is needed to
monitor antifungal resistance because reduced ﬂuconazole
susceptibility in non-albicans Candida is not an uncommon
trend. Echinocandins continue to exhibit excellent in vitro
fungicidal activities against all Candida isolates and are
promising agents for the treatment of patients with invasive
candidiasis, particularly in ICU patients.
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Candida albicans is the most common opportunistic fungal
pathogen of humans. It causes from benign infections such
as oral and vaginal candidiasis to fatal, systematic infections
in immunocompromised or critically ill patients. The
genotype distributions of C. albicans strains with different
sources were investigated using single-strand conformation
polymorphism and GeneScan analyses of a microsatellite
locus called CAI. The C. albicans strains from various
extragenital sites, those from vaginas of asymptomatic
women, and those causing vulvovaginal candidosis (VVC) of
women and balanoposthitis of men, were employed. Genetic
similarity of representative strains with the same and
different CAI genotypes were examined by sequence analysis
of housekeeping genes CaADP1, CaSYA1 and CaVPS13.
The CAI genotypes of independent C. albicans strains from
extragenital sites were mostly of individual speciﬁcity.
In contrast, strains associated with VVC were mainly
concentrated to a few dominant genotypes, with two CAI
genotypes being the most common. The enrichment trend
of the dominant genotypes of C. albicans strains correlated
positively with the severity of VVC. A similar biased genotype
distribution pattern of C. albicans strains associated with
balanoposthitis was also revealed. The genetic similarity of
strains with the dominant genotypes associated with both
VVC and balanoposthitis was conﬁrmed by sequence analysis
of the three genes. The results suggest the existence of
vaginopathic C. albicans strains with enhanced virulence
and tropism for the vagina, and the high possibility of sexual
transmission of genital C. albicans infection. Identiﬁcation
of speciﬁc genotypes that correlate with severity of VVC is
certainly of diagnostic and therapeutic signiﬁcance.
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In recent years, as the growing number of immunocompro-
mised hosts, there is an obviously increasing of opportunistic
fungal infections. Candida infection is the commonest one
especially Candidemia could lead to a high mortality.
Other non-Candida yeasts infections are emerging, such
as Trichosporon spp. infection. In BMT patients and other
immunocompromised patients, invasive aspergillosis has
been one of the major causes of death. How to improve
the early and speciﬁc diagnosis level of fungal infection,
especially the invasive fungal infection, is a big challenge
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to the clinical mycologists. There is an urgent need to
develop the new diagnosis procedures such as the non-
culture methods though the detection of the fungal antigen
and nuclear acid. The application of 1,3-b-D-Glucan (G-
test) and Glactomann (GM test) as well as the PCR related
procedures will be discussed in this presentation. In future,
multi-centered prospective study is still needed to the
better evaluation of these methods.
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Penicillium marneffei was ﬁrst isolated from the visceral
organs of bamboo rats in Vietnam in1956. It is considered as
an endemic pathogen of the Southeast Asia and South China.
Sporadic case reports were cases living in or having travelled
to these regions. It can affect both apparent normal hosts
and immunocompromized hosts such as lymphoma. In the
AIDS era, outburst of cases was reported from the North
of Thailand. Between 1991- 1996, there were 1,020 cases
diagnosed in Chiangmai University Hospital, all were HIV-
infected people. Hence, this infection is considered an
AIDS-deﬁning illness in this part of the world.
Penicilliosis marneffei was also reported in AIDS cases
in Manipur State in West India. Transmission is
most likely via inhalation of infective spores in the
environment. Roles of bamboo rats remain unclear. Clinical
features of disseminated infection include prolonged
fever (98%), anemia (75%), weight loss (70%), cutaneous
lesions (70%), lymphadenopathy (52%), hepatomegaly (45%),
lung involvement (35%), splenomegaly (14%), and osteolytic
lesions (4%). Diagnosis can easily be made quickly by
demonstrating intra- and extracellular yeasts, 3 5 micron
in size, some elongated with septum centrally, on Wright’s
stain of the skin-scraping. Peripheral blood smear, bone
marrow smear, lymphnode touch-prep are also helpful in
making diagnosis. Conﬁrmation by culture requires more
time. Treatment should be started with Amphotericin B
(0.6mg/kg/d) for 2 weeks, followed by itrconazole
(200mgbid) for another 10 weeks. Secondary prophylaxis
should be given to prevent relapse until immune recovery
with HAART.
Another unique mycosis in this region is pythiosis,
the infection caused by Pythium insidiosum. The most
recognized form with high morbidity and mortality
is arteritis, presenting with symptoms and signs of
arterial insufﬁciency: intermittent claudication, chronic
ischemic ulcers or limb gangrene, mainly of lower limbs.
Pathologically, the infection spread along the arterial
vessel wall, causing destruction, thrombosis, or aneurysmal
dilatation, in the ascending fasion towards aorta. False
aneurysm is observed. Aortic rupture is ultimately fatal
outcome. Almost all patients have hemoglobinopathy/
thalassemic syndrome and expose to this organisms in
the environment such as rice ﬁeld. Treatment of this
entity is still problematic since it is not a true fungus
and the response to the available antifungal agents is
unsatisfactory. Some successful treatment reported includes
the combination of itraconazole and terbinaﬁne, and
immunotherapy with Pythium Vaccine developed by Dr.
Mendoza. Amputation of the affected limb is usually
unavoidable. Ocular form is also devastating. It progresses
from corneal ulcer, invading deeper into the globe resulting
in endophthalmitis, nonresponsive to any topical antifungal
agents. Enucleation or evisceration is the usual outcome.
Considering its habitat in the tropic, it is likely that pythiosis
is under- recognized in the Southeast Asia region, and
physicians should be aware of this infection and manage
early to reduce the morbidity and mortality.
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Background: It is well known that OIs are the main causes
of HIV/AIDS patients’ hospitalizations and deaths. With
the different immune system status, the OIs spectrum is
different. With the introductions of HAART, the incidence
and mortality of OIs will be declined greatly. But as we know,
the impaired immune system function will be reconstituted
after HAART of 3 6 months at least. The OIs still have chance
to happen during the ﬁrst 6 months after HAART initiation.
During the ﬁrst 6 months, not only the side effects of the ARV
drugs but also IRIS will make the diagnosis of OIs difﬁcult.
Objective: To explore the changes and distributions status
of Opportunistic Infections during 6 months after HAART
initiation.
Methods: To research retrospectively and prospectively with
the uniform CRF. The contents of the CRF include the data
below: subject number, the date of the HAART initiation,
gender, age, ARV regimen, OI status during 3 months before
HAART, and 2 weeks, 2 weeks to 3 months, 3 6 months
after HAART respectively, and CD4 cell counts changes of
baseline, 3 months and 6 months of treatments.
Results: 93 patients had the symptom of fever during
3 months before treatments among 192 patients. The
incidence of fever is 48.44%. 39 cases had the symptom of
diarrhea (20.31%). 46 patients had TB (35.9%); the baseline
CD4 cell count is 91/ml; after 2 weeks treatment, the fever
incidence rate is 35.9%, 3.65% is new onset. The incidence
rate of respiratory system disease is 29.69% (57 cases).
56.1% cases are TB. Among them only 3 cases are newly
diagnosed or infected with TB. The incidences of oral thrush
(12.5%) and herpes zoster (14.6%) are relatively high. The
respiratory system symptom incidence rate is 2.08% at the
week 2 month 3 of treatments, oral thrush (1.56%) and
herpes zoster (1.56%). And there is no new TB case; there
are still the cases of fever and lung disease. But the rate
is very low; The CD4 cell count increased 111/ml after 6
months treatments.
Conclusions: Fever is the most common sign of the AIDS
patient. The incidence of fever will be reduced greatly as
the HAART continues (P< 0.05). And whether a patients has
a fever is related with his fever status before the treatment.
Swallow difﬁculty and pain become less (P< 0.05). TB, oral
thrush, lung disease and herpes zoster have been reduced
signiﬁcantly (P< 0.05). The diarrhea becomes less but the
difference is not signiﬁcant (P> 0.05). Perhaps, it is because
that the diarrhea is related with not only the OI but also
the side effects of drugs and non-speciﬁc inﬂammations. We
can not make the right judgements on the neuro system
features and vision changes.
